Health Canada’s recent approval of ELAHERE® for a challenging form of cancer marks a step forward for AbbVie in oncology, enhancing its presence in a high-need therapeutic area. Alongside this, the updated results presented from its EPCORE® NHL-6 trial further underscore the company’s commitment to advancing treatments in oncology. Yet, despite these developments, AbbVie’s stock…
A decade ago, treating cancer with personalised mRNA vaccines seemed like a US$1 million gamble per patient, a therapy reserved for the ultra-rich. But Chinese biotech start-ups are aiming to change that – by designing cancer therapy for a fraction of the cost and also taking on Western pharmaceutical giants in the process. Beijing-based Likang…
Oncology nurses and APPs play a large role in recruitment for clinical trials and should stay informed on what clinical trial may be relevant to their patients, according to expert Erica Doubleday, MS, FNP-C, BSN, RN. Doubleday stated in an interview with Oncology Nursing News that oncology nurses and APPs have a responsibility to keep…
The deceased doctor who was part of a suspected Shiga toxin-producing E coli cluster in a Hong Kong public hospital was described as “a good role model” for colleagues and “willing to go the extra mile” to help patients, according to people familiar with him. The doctor, whose name was not revealed by the authorities,…
Sung, H. et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. Cancer J. Clin. 71, 209–249 (2021). Article MATH Google Scholar NCD Countdown. : worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4. Lancet.392, 1072-88. (2018). Trends in adult. Body-mass…
SHANGHAI, Nov. 8, 2024 /PRNewswire/ — Illumina Hong Kong LIMITED (Illumina), a global leader in DNA sequencing and array-based technologies, and PHASE Scientific International Limited (PHASE), a Hong Kong-based biotech company with operations in the U.S. and the Greater Bay Area (GBA), signed a three-year Memorandum of Understanding (MoU) on 7 November at the 7th…